Testing effectiveness (Phase 2)WithdrawnNCT01723670
What this trial is testing
Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
Who this might be right for
Alzheimer's Disease
CERESPIR